PINE BROOK, N.J., July 31, 2013 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a biopharmaceutical company developing antibody therapies to treat infectious disease, today released data from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback